+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

From
From
From
Rhabdomyosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Rhabdomyosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Ewing Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
From
Obesity: Competitive Landscape to 2026 - Product Thumbnail Image

Obesity: Competitive Landscape to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
Dravet Syndrome- Pipeline Insight, 2024 - Product Thumbnail Image

Dravet Syndrome- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Glycan Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Glycan Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator